FI925946L - Nya 2-sackarinylmetylaryl- och -aryloxiacetat anvaendbara som inhibitorer foer proteolytiska ensymer, kompositioner innehaollande dessa och anvaendning av dessa - Google Patents

Nya 2-sackarinylmetylaryl- och -aryloxiacetat anvaendbara som inhibitorer foer proteolytiska ensymer, kompositioner innehaollande dessa och anvaendning av dessa Download PDF

Info

Publication number
FI925946L
FI925946L FI925946A FI925946A FI925946L FI 925946 L FI925946 L FI 925946L FI 925946 A FI925946 A FI 925946A FI 925946 A FI925946 A FI 925946A FI 925946 L FI925946 L FI 925946L
Authority
FI
Finland
Prior art keywords
dessa
och
saccarinylmethylaryl
proteolytiska
ensymer
Prior art date
Application number
FI925946A
Other languages
English (en)
Finnish (fi)
Other versions
FI925946A0 (fi
FI925946A7 (fi
Inventor
Lee Hamilton Latimer
Richard Paul Dunlap
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of FI925946A0 publication Critical patent/FI925946A0/fi
Publication of FI925946L publication Critical patent/FI925946L/fi
Publication of FI925946A7 publication Critical patent/FI925946A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI925946A 1991-12-30 1992-12-30 Uusia 2-sakkarinyylimetyyliaryyli- ja -aryylioksiasetaatteja, jotka ovat käyttökelpoisia proteolyyttisten entsyymien inhibiittoreina, niitä sisältäviä koostumuksia ja niiden käyttö FI925946A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81574091A 1991-12-30 1991-12-30

Publications (3)

Publication Number Publication Date
FI925946A0 FI925946A0 (fi) 1992-12-30
FI925946L true FI925946L (fi) 1993-07-01
FI925946A7 FI925946A7 (fi) 1993-07-01

Family

ID=25218721

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925946A FI925946A7 (fi) 1991-12-30 1992-12-30 Uusia 2-sakkarinyylimetyyliaryyli- ja -aryylioksiasetaatteja, jotka ovat käyttökelpoisia proteolyyttisten entsyymien inhibiittoreina, niitä sisältäviä koostumuksia ja niiden käyttö

Country Status (17)

Country Link
US (3) US5385923A (enExample)
EP (1) EP0550112A1 (enExample)
JP (1) JPH05255286A (enExample)
AU (1) AU651746B2 (enExample)
CA (1) CA2086348A1 (enExample)
CZ (1) CZ386992A3 (enExample)
FI (1) FI925946A7 (enExample)
HU (2) HUT65736A (enExample)
IL (1) IL104259A (enExample)
MX (1) MX9207274A (enExample)
MY (1) MY108926A (enExample)
NO (1) NO303446B1 (enExample)
NZ (1) NZ245586A (enExample)
PH (1) PH30411A (enExample)
RU (1) RU2081871C1 (enExample)
SG (1) SG48025A1 (enExample)
TW (1) TW226016B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
DE19533643A1 (de) * 1995-09-12 1997-03-13 Nycomed Arzneimittel Gmbh Neue cyclische Derivate von Benzolsulfonamiden
DE19748470A1 (de) * 1997-11-03 1999-05-06 Hoechst Schering Agrevo Gmbh Carbamoylphenylsulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren
US20090053221A1 (en) * 2006-01-17 2009-02-26 Cheung Nai-Kong V Immune response enhancing glucan
PT2445502T (pt) 2009-06-25 2017-09-22 Alkermes Pharma Ireland Ltd Compostos heterocíclicos para o tratamento de distúrbios neurológicos e psicológicos
JP5732453B2 (ja) 2009-06-25 2015-06-10 アルカーメス ファーマ アイルランド リミテッド Ｎｈ酸性化合物のプロドラッグ
EP2521711B1 (en) * 2010-01-07 2017-08-16 Alkermes Pharma Ireland Limited Quaternary ammonium salt prodrugs
NZ604423A (en) 2010-06-24 2015-01-30 Alkermes Pharma Ireland Ltd Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
ES2972387T3 (es) 2011-03-18 2024-06-12 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas que comprenden ésteres de sorbitán
WO2013088255A1 (en) 2011-12-15 2013-06-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
CA2867121C (en) 2012-03-19 2021-05-25 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising fatty acid esters
WO2013142202A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising glycerol esters
US9999670B2 (en) 2012-03-19 2018-06-19 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising benzyl alcohol
JP6654042B2 (ja) 2012-09-19 2020-02-26 アルカームス ファーマ アイルランド リミテッド 貯蔵安定性が改善された医薬組成物
WO2015102992A1 (en) 2013-12-31 2015-07-09 Saint-Gobain Abrasives, Inc. Abrasive article including shaped abrasive particles
US20150253127A1 (en) * 2014-03-04 2015-09-10 Honeywell Asca Inc. Thickness Determination of Web Product by Mid-infrared Wavelength Scanning Interferometry
AU2015231278B2 (en) 2014-03-20 2020-01-23 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
US10346168B2 (en) 2015-06-26 2019-07-09 Microsoft Technology Licensing, Llc Decoupled processor instruction window and operand buffer
AU2019230014B2 (en) 2018-03-05 2024-11-28 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3002884A (en) * 1959-04-15 1961-10-03 Rohm & Haas Horticultural process with n-halomethyl-1,2-benzisothiazolin - 3 - one-1,1-dioxides for controlling fungus diseases
US3314960A (en) * 1964-08-25 1967-04-18 American Home Prod Benzisothiazol glutarimides
FR1451417A (fr) * 1965-07-15 1966-01-07 Roussel Uclaf Nouveaux esters d'acides cycliques et leur procédé de préparation
JPS4835457A (enExample) * 1971-09-02 1973-05-24
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4263393A (en) * 1979-09-06 1981-04-21 Eastman Kodak Company Novel electron donor precursors and photographic element containing them
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4363865A (en) * 1981-03-04 1982-12-14 Eastman Kodak Company Imido methyl blocked photographic dyes and dye releasing compounds
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
US4547371A (en) * 1983-04-18 1985-10-15 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
US4623645A (en) * 1983-04-18 1986-11-18 Merck & Co., Inc. Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents
US4659855A (en) * 1983-05-09 1987-04-21 Georgia Tech Research Corporation Aryl sulfonyl fluoride compounds
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
EP0253029A1 (en) * 1986-07-10 1988-01-20 Keng-Ben Wang A distilled drinking water fountain
US5128339A (en) * 1990-11-01 1992-07-07 Sterling Winthrop Inc. Proteolytic enzyme inhibition method
KR0183397B1 (ko) * 1989-05-04 1999-05-01 존 엠. 스피나토 단백질 분해 효소 저해제로서 유용한 사카린 유도체들 및 그의 제조방법
FR2659327A1 (fr) * 1990-03-08 1991-09-13 Centre Nat Rech Scient Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5279758A (en) * 1991-10-22 1994-01-18 The Clorox Company Thickened aqueous cleaning compositions
AU656027B2 (en) * 1991-11-15 1995-01-19 Sanofi Saccharin derivative proteolytic enzime inhibitors
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
JPH07200419A (ja) * 1993-12-28 1995-08-04 Nec Corp バスインタフェース装置
DE4420271B4 (de) * 1994-06-10 2007-09-27 Robert Bosch Gmbh Zündspulensatz für eine Mehrzylinder-Brennkraftmaschine

Also Published As

Publication number Publication date
US5489604A (en) 1996-02-06
MX9207274A (es) 1993-06-01
US5783589A (en) 1998-07-21
PH30411A (en) 1997-05-09
US5385923A (en) 1995-01-31
NZ245586A (en) 1994-11-25
AU2966992A (en) 1993-07-01
SG48025A1 (en) 1998-04-17
FI925946A0 (fi) 1992-12-30
CA2086348A1 (en) 1993-07-01
HU9204166D0 (en) 1993-04-28
CZ386992A3 (en) 1993-09-15
FI925946A7 (fi) 1993-07-01
IL104259A0 (en) 1993-05-13
NO925041D0 (no) 1992-12-30
NO303446B1 (no) 1998-07-13
RU2081871C1 (ru) 1997-06-20
TW226016B (enExample) 1994-07-01
HU211625A9 (en) 1995-12-28
EP0550112A1 (en) 1993-07-07
AU651746B2 (en) 1994-07-28
MY108926A (en) 1996-11-30
JPH05255286A (ja) 1993-10-05
HUT65736A (en) 1994-07-28
NO925041L (no) 1993-07-01
IL104259A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
FI921850A7 (fi) Anvaendning av sulfonamider som laekemedel och nya sulfonamider
FI921183L (fi) Nya bensofusionerade laktamer, som fraemjar frigivning av tillvaexthormon
FI934000L (fi) Nya estrar av bi- och tricykliska aminoalkoholer, deras framstaellning och deras anvaendning i laekemedel
FI925735L (fi) Polymerer och oligomerer av gallsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI921952A0 (fi) Foerfarande foer framstaellning av dialkylenpiperidinofoereningar och enantiomerer daerav anvaendbara som laekemedel.
FI924312L (fi) Nya karboxialkylderivat, vilka aer anvaendbara som inhibitorer av enkefalinas och ace
FI914833L (fi) Nya substituerade azetidinoner som antiinflammatoriska och antidegenerativa aemnen.
FI933252L (fi) Nya amylinagonistpeptider och anvaendning som amylinagonister
FI934109L (fi) Bensoylguanidiner, foerfarande foer framstaellning av dessa, deras anvaendning som laekemedel och laekemedel innehaollande dessa
FI933253A0 (fi) Nya amylinantagonistpeptider och anvaendning som amylinantagonister
FI933856A7 (fi) Foerfarande och anordning behandling av organiska aemnen, speciellt spillvatten som innehaoller organiska klorfoereningar fraon epiklorhydrinframstaellning
FI923558A0 (fi) Tetrahydroindazol-, tetrahydrocyklo -pentapyrazol- och hexahydrocykloheptapyrazolfoereningar och deras anvaendning som inhibitorer av hmg-coa-reduktas.
FI923185A0 (fi) Foerfarande och anordning foer framstaellning av fogloesa band- och traodoeglor och deras anvaendning som kapverktyg i band- och traodsaogar.
FI925946A0 (fi) Nya 2-sackarinylmetylaryl- och -aryloxiacetat anvaendbara som inhibitorer foer proteolytiska ensymer, kompositioner innehaollande dessa och anvaendning av dessa
FI921327L (fi) Nya azadekalinamider och tioamider som inhibitorer av kolesterolbiosyntes
FI925665L (fi) Nya pyridylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI911700A7 (fi) Anvaendning av n-alkylerade 1,4 -dihydropyridinkarboxylsyraestrar som laekemedel, nya foereningar och foerfarande foer deras framstaellning.
FI925947L (fi) Nya heterocykliska 2-sackarinylmetylkarboxylat, vilka aer anvaendbara som inhibitorer foer proteolytiska enzymer, kompositioner innehaollande dessa och anvaendning av dessa
FI913556L (fi) Nya piperidyletrar och -tioetrar som inhibitorer av kolesterolbiosyntes.
FI920349L (fi) Foerfarande foer framstaellning av nya tetrazolderivat och deras anvaendning.
FI916144L (fi) Nya silika, foerfarande foer deras framstaellning och deras anvaendning som tillsatsmedel vid framstaellning av papper.
FI923050L (fi) Nya benzomorfaner och deras anvaendning som laekemedel
FI932145L (fi) Nya b-karbolinderivat, deras framstaellning och anvaendning i laekemedel
FI915163A0 (fi) Nya 2-sackarinylmetylarylkarboxylater anvaendbara som inhibitorer foer proteolytiskt enzym och kompositioner och metoder foer deras anvaendning.
FI921340L (fi) Nya tiazolidinon- och oxazolidinonderivat, deras framstaellning och anvaendning som utvidgare av blodkaerlen

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SANOFI